Evoke Pharma Stock Forecast

Buy or Hold candidate since Nov 05, 2025

No changes to the price of Evoke Pharma stock on the last trading day (Monday, 17th Nov 2025). During the last trading day the stock fluctuated 0.328% from a day low at $10.67 to a day high of $10.71. The price has risen in 5 of the last 10 days and is up by 132.9% over the past 2 weeks.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $10.92 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 49.03% during the next 3 months and, with a 90% probability hold a price between $7.68 and $16.28 at the end of this 3-month period.

EVOK Signals & Forecast

The Evoke Pharma stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $10.69 and $6.45. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, November 11, 2025, and so far it has fallen -0.0935%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Evoke Pharma stock

Evoke Pharma finds support from accumulated volume at $10.68 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0350 between high and low, or 0.328%. For the last week, the stock has had daily average volatility of 0.328%.

The Evoke Pharma stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stock may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $10.34 (-3.23%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 90 and this increases the risk substantially. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (EVOK) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Evoke Pharma to open at $10.69, and during the day (based on 14 day Average True Range), to move between $10.48 and $10.90, which gives a possible trading interval of +/-$0.413 (+/-3.94%) up or down from last closing price. If Evoke Pharma takes out the full calculated possible swing range there will be an estimated 3.94% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $10.70 (0.09%) than the support at $10.68 (0.09%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Evoke Pharma stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Evoke Pharma stock to perform well in the short-term.

Current score: 2.730 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $10.69 ( 0.0156%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk